These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7553641

  • 1. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N, Belldegrun A, Bonavida B.
    Cancer Res; 1995 Oct 15; 55(20):4633-9. PubMed ID: 7553641
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.
    Clin Cancer Res; 1997 Jun 15; 3(6):963-72. PubMed ID: 9815772
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 4. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
    Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O.
    Cancer Res; 1995 Feb 01; 55(3):590-6. PubMed ID: 7834629
    [Abstract] [Full Text] [Related]

  • 5. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 6. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
    Frost P, Ng CP, Belldegrun A, Bonavida B.
    Cell Immunol; 1997 Aug 25; 180(1):70-83. PubMed ID: 9316641
    [Abstract] [Full Text] [Related]

  • 7. Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
    Uslu R, Jewett A, Bonavida B.
    Gynecol Oncol; 1996 Aug 25; 62(2):282-91. PubMed ID: 8751562
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 9. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
    Smith PC, Keller ET.
    Prostate; 2001 Jun 15; 48(1):47-53. PubMed ID: 11391686
    [Abstract] [Full Text] [Related]

  • 10. Endogenous interleukin 6 conveys resistance to cis-diamminedichloroplatinum-mediated apoptosis of the K562 human leukemic cell line.
    Dedoussis GV, Mouzaki A, Theodoropoulou M, Menounos P, Kyrtsonis MC, Karameris A, Maniatis A.
    Exp Cell Res; 1999 Jun 15; 249(2):269-78. PubMed ID: 10366426
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1.
    Carollo M, Parente L, D'Alessandro N.
    Oncol Res; 1998 Jun 15; 10(5):245-54. PubMed ID: 9802059
    [Abstract] [Full Text] [Related]

  • 12. In vitro modulation of cisplatin resistance by cytokines.
    Poppenborg H, Knüpfer MM, Galla HJ, Wolff JE.
    Cytokine; 1999 Sep 15; 11(9):689-95. PubMed ID: 10479405
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
    Alas S, Emmanouilides C, Bonavida B.
    Clin Cancer Res; 2001 Mar 15; 7(3):709-23. PubMed ID: 11297268
    [Abstract] [Full Text] [Related]

  • 14. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
    Uslu R, Bonavida B.
    Cancer; 1996 Feb 15; 77(4):725-32. PubMed ID: 8616765
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
    Okamoto M, Lee C, Oyasu R.
    Cancer Res; 1997 Jan 01; 57(1):141-6. PubMed ID: 8988055
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 01; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 17. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan 01; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 18. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
    Mizutani Y, Yoshida O, Miki T, Bonavida B.
    Clin Cancer Res; 1999 Sep 01; 5(9):2605-12. PubMed ID: 10499639
    [Abstract] [Full Text] [Related]

  • 19. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B.
    Clin Cancer Res; 2001 Dec 01; 7(12):3874-83. PubMed ID: 11751478
    [Abstract] [Full Text] [Related]

  • 20. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.